Barnett & Company, Inc. Eli Lilly & CO Transaction History

Barnett & Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $4,693 - $5,833	-20 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $4,497 - $5,580	20 New	20 $6,000
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $31,166 - $36,685	-280 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$77.07 - $85.54 $21,579 - $23,951	280	280 $24,000

4,033

737M

8.26M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Barnett & Company, Inc. with notifications on news.